Markets : Uganda

Quality Chemical Industries Limited, formerly Cipla Quality Chemical Industries Limited, is a pharmaceutical manufacturer. The Company is engaged in manufacturing and selling pharmaceutical drugs with emphasis on antiretroviral (ARVs) and Artemisinin-based Combination Therapy (ACTs). It manufactures ACTs and hepatitis medicines to treat human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome, malaria and hepatitis. It offers three-in-one fixed-dose combination to fight AIDS. Its HIV product portfolio includes Lamivudine and Zidovudine Tablets, Efavirenz Tablets, Lamivudine and Tenofovir Disoproxil Fumarate Tablets, Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate Tablets, Dolutegravir, Lamivudine and Tenofovir Disoproxil Fumarate, and Lamivudine, Zidovudine and Nevirapine Tablets. Its antimalarials product portfolio includes Artemether + Lumefantrine tablets. Its hepatitis product portfolio includes Entecavir tablets and Tenofovir disoproxil fumarate tablets.